MD Conference Express TCT 2011 - (Page 1)

Peer-Reviewed CARDIOLOGY Scientific Sessions PRESENTS HIGHLIGHTS FROM THE Transcatheter Cardiovascular Therapeutics 2011 Interventional Conference Breaking News Therapy Updates November 7-11, 2011 San Francisco, CA, USA TAVI Improves QoL in Patients Suitable for Transfemoral TAVI Transcatheter aortic valve implantation (TAVI) is a less invasive alternative to surgical aortic valve replacement (SAVR) for high-risk patients with aortic stenosis. In PARTNER [NCT00530894; Leon MB et al. NEJM 2010] Cohort A, TAVI was shown to be noninferior to SAVR for 1-year mortality in patients who were at high surgical risk. There were differences in procedurerelated complications and valve performance at 1 year, with some endpoints favoring TAVI and others favoring SAVR. See page 4. A Professional Courtesy of • Point-of-Care Genetic Testing ALSO IN THIS ISSUE • BRIDGE Study Results • PARTNER Cohort Subanalyses  http://www.mdconferencexpress.com http://www.tctconference.com/

Table of Contents for the Digital Edition of MD Conference Express TCT 2011

MD Conference Express TCT 2011
Contents
TAVI Improves QoL in Patients Suitable for Transfemoral TAVI: PARTNER Cohort A
Results from the PARTNER Trial (Cohort A): Transfemoral TAVI Economically Attractive but Transapical TAVI More Costly
PARTNER Cohort B: TAVI Superior to Standard Therapy at Two Years
Transapical TAVI Inferior to SAVR in Operable Elderly Patients
Primary Results from ADVISE: Validation of a Vasodilator Independent Measure of Coronary FFR
Point-of-Care Genetic Testing Facilitates Rapid Personalization of Antiplatelet Therapy
Bioabsorbable Polymer Stent Noninferior to Permanent Polymer Stent
BRIDGE Study Demonstrates Feasibility and Safety of Cangrelor

MD Conference Express TCT 2011

https://www.nxtbook.com/nxtbooks/md_conference_express/tct2011
https://www.nxtbookmedia.com